ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Myelodysplastic syndrome (MDS) is a group of clonal hematopoietic neoplasms originating from hematopoietic stem progenitor cells (HSPCs). We previously identified frequent roundabout guidance receptor 1 (ROBO1) mutations in patients with MDS, while the exact role of ROBO1 in hematopoiesis remains poorly delineated. Here, we report that ROBO1 deficiency confers MDS-like disease with anemia and multilineage dysplasia in mice and predicts poor prognosis in patients with MDS. More specifically, Robo1 deficiency impairs HSPC homeostasis and disrupts HSPC pool, especially the reduction of megakaryocyte erythroid progenitors, which causes a blockage in the early stages of erythropoiesis in mice. Mechanistically, transcriptional profiling indicates that Cdc42, a member of the Rho-guanosine triphosphatase family, acts as a downstream target gene for Robo1 in HSPCs. Overexpression of Cdc42 partially restores the self-renewal and erythropoiesis of HSPCs in Robo1-deficient mice. Collectively, our result implicates the essential role of ROBO1 in maintaining HSPC homeostasis and erythropoiesis via CDC42.

[1]  M. Yaspo,et al.  RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia , 2022, Blood.

[2]  Lei Zhang,et al.  TET2 deficiency promotes MDS-associated leukemogenesis , 2022, Blood Cancer Journal.

[3]  Jiwang Zhang,et al.  Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice , 2022, Stem cell reports.

[4]  P. Frenette,et al.  The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow. , 2022, Cell stem cell.

[5]  B. Göttgens,et al.  JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells. , 2021, Blood advances.

[6]  Yi Zheng,et al.  Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity , 2021, Haematologica.

[7]  T. Mak,et al.  IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis. , 2020, Blood.

[8]  Xiaozhong Peng,et al.  HCF-1 promotes cell cycle progression by regulating the expression of CDC42 , 2020, Cell Death & Disease.

[9]  N. Takahashi,et al.  Cdc42 regulates cell polarization and contractile actomyosin rings during terminal differentiation of human erythroblasts , 2020, Scientific Reports.

[10]  Benjamin L. Ebert,et al.  Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes , 2019, Nature Medicine.

[11]  D. Parkinson,et al.  Classic axon guidance molecules control correct nerve bridge tissue formation and precise axon regeneration , 2019, Neural regeneration research.

[12]  K. Pradhan,et al.  U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies , 2019, Nature Cell Biology.

[13]  T. Kitamura,et al.  The role of ASXL1 in hematopoiesis and myeloid malignancies , 2019, Cellular and Molecular Life Sciences.

[14]  S. Ogawa.  Genetics of MDS. , 2019, Blood.

[15]  U. Platzbecker.  Treatment of MDS. , 2019, Blood.

[16]  D. Jesionek-Kupnicka,et al.  The Expression of the SLIT–ROBO Family in Adult Patients with Acute Myeloid Leukemia , 2019, Archivum Immunologiae et Therapiae Experimentalis.

[17]  S. Teimourian,et al.  Slit/Robo Signaling Pathway in Cancer; a New Stand Point for Cancer Treatment , 2019, Pathology & Oncology Research.

[18]  A. Iwama,et al.  Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome. , 2018, Blood.

[19]  Frederik Otzen Bagger,et al.  BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles , 2018, Nucleic Acids Res..

[20]  N. Nassar,et al.  Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization , 2018, Leukemia.

[21]  Saijuan Chen,et al.  Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation , 2018, Cell Research.

[22]  Xiao Li,et al.  Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes , 2017, Scientific Reports.

[23]  D. Bhartiya,et al.  Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells , 2016, Stem Cell Research & Therapy.

[24]  Yang Zhu,et al.  Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes , 2015, Nature Communications.

[25]  A. Karsan,et al.  Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor–TRAF6 signaling , 2015, The Journal of experimental medicine.

[26]  J. Dinman,et al.  Ribosomopathies and the paradox of cellular hypo- to hyperproliferation. , 2015, Blood.

[27]  Zhaomin Li,et al.  Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. , 2014, Blood.

[28]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[29]  P. Hordijk,et al.  Control of human hematopoietic stem/progenitor cell migration by the extracellular matrix protein Slit3 , 2012, Laboratory Investigation.

[30]  M. Gunzer,et al.  Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. , 2012, Cell stem cell.

[31]  J. Geng,et al.  Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis , 2011, Cell Research.

[32]  Thomas L. Dunwell,et al.  Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia , 2009, Epigenetics.

[33]  R. Ono,et al.  AML1 mutations induced MDS and MDS/AML in a mouse BMT model. , 2008, Blood.

[34]  L. Zon,et al.  Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.

[35]  R. Bicknell,et al.  Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration , 2008, Angiogenesis.

[36]  David A. Williams,et al.  Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis. , 2007, Blood.

[37]  G. Bashaw,et al.  Son of Sevenless Directly Links the Robo Receptor to Rac Activation to Control Axon Repulsion at the Midline , 2006, Neuron.

[38]  C. Goparaju,et al.  Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression , 2006, Molecular Cancer.

[39]  M. Moore.  Converging pathways in leukemogenesis and stem cell self-renewal. , 2005, Experimental hematology.

[40]  J. Griffin,et al.  Role of FLT3 in leukemia. , 2002, Current opinion in hematology.

[41]  I. Weissman,et al.  In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.